News Article

Al's Comment:
It was very interesting. A new approach to targeted radiation therapy not only for metastatic tumors but also for primary brain tumors.

Posted on: 10/09/2022

Video of our recent webinar posted to our website!

Topic: A Promising New Targeted Radiation Therapy for Leptomeningeal Metastases

Speaker: Andrew Brenner, M.D., Ph.D., is a Professor of Medicine, Neurology, and Neurosurgery at The University of Texas Health Science Center at San Antonio and principal investigator of the ReSPECT-LM clinical trial (NCT05034497)

The webinar was presented on 10/9/2022 and posted to our web site at https://virtualtrials.org/video2022.cfm?video=202205

Click HERE to return to brain tumor news headlines.

Sponsored by

Please click on the above banner for more details

Al's Comment:
It was very interesting. A new approach to targeted radiation therapy not only for metastatic tumors but also for primary brain tumors.

Video of our recent webinar posted to our website!

find us on

quick links

our newsletter

Sponsored by

Please click on the above banner for more details

Al's Comment: It was very interesting. A new approach to targeted radiation therapy not only for metastatic tumors but also for primary brain tumors.

Video of our recent webinar posted to our website!

find us on

quick links

our newsletter

Al's Comment:
It was very interesting. A new approach to targeted radiation therapy not only for metastatic tumors but also for primary brain tumors.